Search results
Found 6703 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain
Coronavirus COVID-19 General Research
3 February 2021
Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.
Horizon Europe - business as usual for EC funding
3 February 2021
Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
Clinical Trials Coronavirus COVID-19 General Research
2 February 2021
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22- to up to 90-days post vaccination.
Indonesia’s decision to prioritise COVID-19 vaccination to citizens aged 18-59 years old questionable
Coronavirus COVID-19 General
2 February 2021
New WA Handley Chair of Psychiatry appointed
Awards and Appointments General
1 February 2021
Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021. He will be a fellow of Merton College. A donation from the WA Handley Trust endowed the first Chair of Psychiatry in the University of Oxford’s Department of Psychiatry, which was founded in 1969.
European Medicines Agency recommends conditional marketing authorisation to ChAdOx1 coronavirus vaccine
Coronavirus COVID-19
29 January 2021
The European Medicines Agency (EMA) has today recommended the conditional marketing authorisation of the ChAdOx1 nCoV-19 coronavirus vaccine developed by the University of Oxford with its partner AstraZeneca. Distribution will begin across all 27 member states once the decision is ratified by the European Commission.
Oxford Cancer Centre appoints Prof. Tim Elliott as new co-director
Awards and Appointments General
29 January 2021
The CRUK Oxford Centre is pleased to announce the appointment of Professor Tim Elliott as its new co-Director.
Same genome, different worlds: How a similar brain causes sexually dimorphic behaviours
General Research
27 January 2021
A new paper from Department of Physiology, Anatomy & Genetics's Centre for Neural Circuits and Behaviour has shown how males and females are programmed differently in terms of sex.
Oxford University vaccine developer joins day of vaccinations at the Kassam Stadium
Coronavirus COVID-19 General
26 January 2021
Today, Andrew Pollard, Professor of Pediatric Infection and Immunity at the University of Oxford, and chief investigator of the trials of the ChAdOx1 nCoV-19 coronavirus vaccine, volunteered his time to help deliver live-saving Covid vaccinations at the newly opened NHS Vaccine Centre at the Kassam Stadium, Oxford.
New form of gift wrap drives male reproductive success
General Research
26 January 2021
A study from the Department of Physiology, Anatomy and Genetics (DPAG) has identified a new communication mechanism that ensures the transfer of a complex mix of signals and nutrients required for successful reproduction between males and females.
PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
Coronavirus COVID-19 General Research
25 January 2021
In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.
Early animal studies yield promising results for new potential COVID-19 vaccine
Coronavirus COVID-19 General Research
25 January 2021
Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.
Just over half of British Indians would take COVID vaccine
Coronavirus COVID-19 General Research
21 January 2021
University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.
Investigating New Treatment for Schizophrenia
General Innovation Research
21 January 2021
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Joggers and cyclists should wear masks – here’s why
Coronavirus COVID-19 General Research
19 January 2021
Parental mental health worsens under new national COVID-19 restrictions
Coronavirus COVID-19 General Research
19 January 2021
Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.
£100 million donation from Ineos to create new institute to fight antimicrobial resistance
Awards and Appointments General Innovation
19 January 2021
A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
Clinical Trials Coronavirus COVID-19 General Research
18 January 2021
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.
Ancient gene mutation found to cause rare hereditary condition
General Research
18 January 2021
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).